Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2007

01.03.2007

Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy

verfasst von: Christine E. Dauphine, Jason S. Haukoos, Maria P. Vargas, Nova M. Isaac, Iraj Khalkhali, Hernan I. Vargas

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Completion axillary lymph node dissection (cALND), performed after a positive sentinel lymph node biopsy (SLNB) in breast cancer patients, often results in no additional positive nodes. Scoring systems have been published to aid in the prediction of nonsentinel node metastasis. Our purpose was to assess the validity of these scoring systems in our patient population.

Methods

For 39 consecutive patients who underwent cALND after a positive SLNB, scores were calculated using retrospective patient data for each of the three scoring systems used. Receiver operating characteristics (ROC) curves were drawn, and the areas under the curves were calculated to assess the discriminative power of each system. Univariate analysis was performed to assess the predictability of individual patient and tumor characteristics.

Results

Nonsentinel nodes were positive in 23 (59%) patients. The areas under the ROC curves were 0.63, 0.70, and 0.68, respectively. The proportion of sentinel nodes that were positive and the total number of sentinel nodes retrieved were the only individual predictors of nonsentinel node metastasis.

Conclusions

Given the high incidence of retrieving no additional metastasis on cALND, individualized patient management according to risk is desirable. Scoring systems provide additional information regarding the likelihood of metastasis in nonsentinel nodes, but their predictability remains less than optimal. The use of scoring systems must be applied with caution until future studies provide a more accurate assessment of risk for patients with a positive SLNB.
Literatur
1.
Zurück zum Zitat Guiliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345–2350 Guiliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345–2350
2.
Zurück zum Zitat Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349:1864–1867PubMedCrossRef Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349:1864–1867PubMedCrossRef
3.
Zurück zum Zitat Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941–946PubMedCrossRef Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941–946PubMedCrossRef
4.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546–553PubMedCrossRef Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546–553PubMedCrossRef
5.
Zurück zum Zitat Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer. J Clin Oncol 2000; 18:2553–2559PubMed Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer. J Clin Oncol 2000; 18:2553–2559PubMed
6.
Zurück zum Zitat Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003; 10:248–254PubMedCrossRef Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003; 10:248–254PubMedCrossRef
7.
Zurück zum Zitat Barranger E, Coutant C, Flahault A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005; 91:113–119PubMedCrossRef Barranger E, Coutant C, Flahault A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005; 91:113–119PubMedCrossRef
8.
Zurück zum Zitat Chu Ku, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastsis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229:536–541PubMedCrossRef Chu Ku, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastsis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229:536–541PubMedCrossRef
9.
Zurück zum Zitat Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574–581PubMedCrossRef Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574–581PubMedCrossRef
10.
Zurück zum Zitat Joslyn SA, Konety BR. Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat 2005; 91:11–18PubMedCrossRef Joslyn SA, Konety BR. Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat 2005; 91:11–18PubMedCrossRef
11.
Zurück zum Zitat Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 1999; 6:109–116PubMedCrossRef Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 1999; 6:109–116PubMedCrossRef
12.
Zurück zum Zitat Carter CL, Allen C, Henson DC, et al. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 1989; 63:181–187PubMedCrossRef Carter CL, Allen C, Henson DC, et al. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 1989; 63:181–187PubMedCrossRef
13.
Zurück zum Zitat Kakuda JT, Stuntz M, Trivedi V, et al. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg 1999; 65:995–998PubMed Kakuda JT, Stuntz M, Trivedi V, et al. Objective assessment of axillary morbidity in breast cancer treatment. Am Surg 1999; 65:995–998PubMed
14.
Zurück zum Zitat Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005; 23:4312–4321PubMedCrossRef Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005; 23:4312–4321PubMedCrossRef
15.
Zurück zum Zitat Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. The Breast 2004; 13;494–501PubMedCrossRef Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. The Breast 2004; 13;494–501PubMedCrossRef
16.
Zurück zum Zitat Tan YY, Fan YG, Lu Y, et al. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J 2005; 11:248–253PubMedCrossRef Tan YY, Fan YG, Lu Y, et al. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J 2005; 11:248–253PubMedCrossRef
17.
Zurück zum Zitat Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574–581PubMedCrossRef Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574–581PubMedCrossRef
18.
Zurück zum Zitat Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes. Arch Surg 2001; 136:563–568PubMedCrossRef Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes. Arch Surg 2001; 136:563–568PubMedCrossRef
19.
Zurück zum Zitat Guenther JM, Hansen NM, DeFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive nodes. Arch Surg 2003; 138:52–56PubMedCrossRef Guenther JM, Hansen NM, DeFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive nodes. Arch Surg 2003; 138:52–56PubMedCrossRef
20.
Zurück zum Zitat Schrenk P, Konstantiniuk P, Wolfl S, et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005; 92:707–713PubMedCrossRef Schrenk P, Konstantiniuk P, Wolfl S, et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005; 92:707–713PubMedCrossRef
21.
Zurück zum Zitat Van Zee K, Manasseh DME, Becilacqua JLB, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10:1140–1151PubMedCrossRef Van Zee K, Manasseh DME, Becilacqua JLB, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10:1140–1151PubMedCrossRef
22.
Zurück zum Zitat Vargas HI, Tolmos J, Agbunag RV, et al. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer. Am Surg 2002; 68:87–91PubMed Vargas HI, Tolmos J, Agbunag RV, et al. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer. Am Surg 2002; 68:87–91PubMed
23.
Zurück zum Zitat Cady, Blake. A contemporary view of axillary dissection. Ann Surg 2000; 232:8–9 Cady, Blake. A contemporary view of axillary dissection. Ann Surg 2000; 232:8–9
24.
Zurück zum Zitat Fant JS, Grant MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10:126–130PubMedCrossRef Fant JS, Grant MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10:126–130PubMedCrossRef
25.
Zurück zum Zitat International Breast Cancer Study Group. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10-93. J Clin Oncol 2006; 24:337–344CrossRef International Breast Cancer Study Group. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10-93. J Clin Oncol 2006; 24:337–344CrossRef
26.
Zurück zum Zitat Fisher B, Montague E, Redmond C, et al. Findings of NSABP Protocol No. B-04 – comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1980; 46:1–13PubMedCrossRef Fisher B, Montague E, Redmond C, et al. Findings of NSABP Protocol No. B-04 – comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1980; 46:1–13PubMedCrossRef
27.
Zurück zum Zitat Louis-Silvester C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004; 22:97–101CrossRef Louis-Silvester C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004; 22:97–101CrossRef
28.
Zurück zum Zitat Specht MC, Kattan MW, Gonen M, et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005; 12:654–659PubMedCrossRef Specht MC, Kattan MW, Gonen M, et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005; 12:654–659PubMedCrossRef
29.
Zurück zum Zitat Smidt ML, Kuster DM, Jan van der Wilt G, et al. Can the Memorial Sloan-Kettering Cancer Center Nomogram predict the likelihood of nonsentinel node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005; 12:1066–1072PubMedCrossRef Smidt ML, Kuster DM, Jan van der Wilt G, et al. Can the Memorial Sloan-Kettering Cancer Center Nomogram predict the likelihood of nonsentinel node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005; 12:1066–1072PubMedCrossRef
Metadaten
Titel
Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy
verfasst von
Christine E. Dauphine
Jason S. Haukoos
Maria P. Vargas
Nova M. Isaac
Iraj Khalkhali
Hernan I. Vargas
Publikationsdatum
01.03.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9223-5

Weitere Artikel der Ausgabe 3/2007

Annals of Surgical Oncology 3/2007 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.